LOAMU
EPRS

Lombard Odier Asset Management (USA)’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-126,807
Closed -$724K – 252
2015
Q2 		$724K Sell
126,807
-57,372
-31% -$392K 0.05% 167
2015
Q1 		$1.65M Buy
+184,179
New +$1.48M 0.13% 137

Other funds holding EPRS

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s EPRS Position: Q3 2015 in Review

Lombard Odier Asset Management (USA) sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2015, closing a stake of 126,807 shares — an estimated $724K sold.

Lombard Odier Asset Management (USA) first reported a position in EPRS in Q1 2015 and held it in 2 quarters. The position peaked at $1.65M in Q1 2015. 41 funds tracked by Wall St. Rank hold EPRS as of Q3 2015.

  • Lombard Odier Asset Management (USA) reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2015 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 126,807 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2015, an estimated $724K.
  • Lombard Odier Asset Management (USA) first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $1.65M in Q1 2015.
  • 41 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2015.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2015, filed 16 Nov 2015.